Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background —Use of β-adrenoreceptor blockade in the treatment of heart failure has been associated with a reduction in myocardial oxygen consumption and an improvement in myocardial energy efficiency. One potential mechanism for this beneficial effect is a shift in myocardial substrate use from increased free fatty acid (FFA) oxidation to increased glucose oxidation. Methods and Results —We studied the effect of carvedilol therapy on myocardial FFA and glucose use in 9 patients with stable New York Heart Association functional class III ischemic cardiomyopathy (left ventricular ejection fraction ≤35%) using myocardial positron emission tomography studies and resting echocardiograms before and 3 months after carvedilol treatment. Myocardial uptake of the novel long chain fatty acid metabolic tracer 14(R, S)-[ 18 F]fluoro-6-thia-heptadecanoic acid ([ 18 F]-FTHA) was used to determine myocardial FFA use, and [ 18 F]fluoro-2-deoxy-glucose ([ 18 F]-FDG) was used to determine myocardial glucose use. After carvedilol treatment, the mean myocardial uptake rate for [ 18 F]-FTHA decreased (from 20.4±8.6 to 9.7±2.3 mL · 100 g –1 · min –1 ; P <0.005), mean fatty acid use decreased (from 19.3±7.0 to 8.2±1.8 μmoL · 100 g –1 · min –1 ; P <0.005), the mean myocardial uptake rate for [ 18 F]-FDG was unchanged (from 1.4±0.4 to 2.4±0.8 mL · 100 g –1 · min –1 ; P =0.14), and mean glucose use was unchanged (from 11.1±3.1 to 18.7±6.0 μmoL · 100 g –1 · min –1 ; P =0.12). Serum FFA and glucose concentrations were unchanged, and mean left ventricular ejection fraction improved (from 26±2% to 37±4%; P <0.05). Conclusions —Carvedilol treatment in patients with heart failure results in a 57% decrease in myocardial FFA use without a significant change in glucose use. These metabolic changes could contribute to the observed improvements in energy efficiency seen in patients with heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart
Sack, M. N., Rader, T. A., Park, S., Bastin, J., McCune, S. A., & Kelly, D. P. (1996) · Circulation · doi:10.1161/01.cir.94.11.2837 · Cited by 677
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 635
Packer, M., Colucci, W. S., Sackner-Bernstein, J. D., Liang, C.-S., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2793 · Cited by 613
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00245-3 · Cited by 606
Hjemdahl, P., Daleskog, M., & Kahan, T. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90384-9 · Cited by 569
Principles and Practice of Echocardiography
Weyman, A. E. (1994) · Medical Entomology and Zoology · Cited by 558
Hall, S. A., Cigarroa, C. G., Marcoux, L., Risser, R. C., Grayburn, P. A., & Eichhorn, E. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00543-y · Cited by 537
Bing, R. J., Siegel, A., Ungar, I., & Gilbert, M. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90365-4 · Cited by 439
RANDLE, P. J. (1986) · Biochemical Society Transactions · doi:10.1042/bst0140799 · Cited by 311
Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact Dogs
Mjøs, O. D. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106621 · Cited by 309
Eichhorn, E. J., Heesch, C. M., Barnett, J. H., Alvarez, L. G., Fass, S. M., Grayburn, P. A., Hatfield, B. A., Marcoux, L. G., & Malloy, C. R. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90114-7 · Cited by 306
Taylor, M., Wallhaus, T. R., DeGrado, T. R., Russell, D. C., Stanko, P., Nickles, R. J., & Stone, C. K. (2001) · PubMed · Cited by 254
Self-citationEichhorn, E. J., Bedotto, J. B., Malloy, C. R., Hatfield, B. A., Deitchman, D., Brown, M., Willard, J. E., & Grayburn, P. A. (1990) · Circulation · doi:10.1161/01.cir.82.2.473 · Cited by 243
Increased glycolytic metabolism in cardiac hypertrophy and congestive failure
Bishop, S., & Altschuld, R. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.218.1.153 · Cited by 212
The Heart: Physiology and Metabolism
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-336_3 · Cited by 193
Influence of free fatty acids on myocardial oxygen consumption and ischemic injury
Vik-Mo, H., & Mjøs, O. D. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90621-4 · Cited by 167
Total-body and myocardial substrate oxidation in congestive heart failure
Paolisso, G., Gambardella, A., Galzerano, D., D'Amore, A., Rubino, P., Verza, M., Teasuro, P., Varricchio, M., & D'Onofrio, F. (1994) · Metabolism · doi:10.1016/0026-0495(94)90241-0 · Cited by 166
Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart
Kjekshus, J. K., & Mjøs, O. D. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106978 · Cited by 165
Defective lipid metabolism in the failing heart
Wittel, B., & Spann, J. F. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105868 · Cited by 144
Analysis of techniques to obtain plasma for measurement of levels of free fatty acids
Zambon, A., Hashimoto, S., & Brunzell, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39687-5 · Cited by 143
Free Fatty Acid Kinetics and Oxidation in Congestive Heart Failure
Lommi, J., Kupari, M. M., & Yki‐Järvinen, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00804-7 · Cited by 129
Panchal, A. R., Stanley, W. C., Kerner, J., & Sabbah, H. N. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90252-4 · Cited by 104
Lopaschuk, G. D., & Spafford, M. (1989) · Circulation Research · doi:10.1161/01.res.65.2.378 · Cited by 99
Effect of inhibition of lipolysis on myocardial oxygen consumption in the presence of isoproterenol
Mjøs, O. D. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106679 · Cited by 91
Eichhorn, E. J., Heesch, C. M., Risser, R. C., Marcoux, L., & Hatfield, B. A. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00340-v · Cited by 70
Higgins, A. J., Morville, M., Burges, R. A., Gardiner, D. G., Page, M. G., & Blackburn, K. J. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90106-x · Cited by 68
Mäki, M. T., Haaparanta‐Solin, M., Nuutila, P., Oikonen, V., Luotolahti, M., Eskola, O., & Knuuti, J. M. (1998) · PubMed · Cited by 64
α-Adrenergic Stimulation Mediates Glucose Uptake Through Phosphatidylinositol 3-Kinase in Rat Heart
Doenst, T., & Taegtmeyer, H. (1999) · Circulation Research · doi:10.1161/01.res.84.4.467 · Cited by 54
Capaldo, B., Napoli, R., di Marino, L., & Saccá, L. (1992) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(92)90301-p · Cited by 36
Cited by
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Myocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,048
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Cardiovascular remodelling in coronary artery disease and heart failure
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60107-0 · Cited by 734
Metadata
- Authors
- Wallhaus, T. R., Taylor, M., DeGrado, T. R., Russell, D. C., Stanko, P., Nickles, R. J., & Stone, C. K.
- Venue
- Circulation
- Published
- 2001-05-22
- Volume
- 103
- Issue
- 20
- Pages
- 2441-2446
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2015145254
- Cited by
- 253
- References
- 32
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.